Back HIV/AIDS

HIV / AIDS

IDWeek 2014: HIV Care Cascade at Kaiser Permanente Varies by Sex and Age

Though there has been improving performance of healthcare delivery at each point of the HIV care cascade, from linkage to care through viral suppression, "success varies significantly by age and gender, even in an integrated care system with equal access to care,” Michael Horberg of the Mid-Atlantic Permanente Research Institute reported yesterday at IDWeek 2014 in Philadelphia.

alt

Researchers Capture Images of HIV Spike Proteins that Allow Cell Entry

A team of researchers from the National Institutes of Health, Yale University, and Weill Cornell Medical College has found a way to visualize the activity of "spikes" on the surface of the HIV-1 envelope that change structure to enable the virus to enter host cells, according to reports published simultaneously in the October 8 editions of Science and Nature.

alt

UNAIDS: "Fast Track" Strategy Could Help End AIDS Epidemic by 2030

A rapid acceleration of HIV prevention and treatment efforts over the next 5 years directed at people most at risk in high prevalence areas could help turn the tide in the AIDS epidemic, according to participants at a recent high-level meeting during the 69th United Nations General Assembly. If fully implemented, this approach could potentially prevent 18 million new HIV infections and 11 million deaths by 2030, as well as reducing future costs.

alt

Second Potentially Cured Baby Has HIV Relapse Soon After Stopping Treatment

An Italian child who started antiretroviral treatment soon after birth and had undetectable plasma viral load, no apparent HIV DNA, and tested HIV antibody negative nevertheless experienced viral rebound shortly after a treatment interruption, once again disappointing hopes for a cure, researchers reported in the October 4 edition of The Lancet.

alt

USCA 2014: U.S. Conference on AIDS Underway in San Diego

The 18th annual U.S. Conference on AIDS, sponsored by the National Minority AIDS Council, is taking place this week in San Diego. While other conferences focus on new data about antiretroviral therapy and biomedical prevention, USCA emphasizes the social, economic, and cultural aspects of HIV/AIDS.

alt

HIVMA Issues Guidelines for Managing Chronic Kidney Disease in People with HIV

The HIV Medical Association (HIVMA) of the Infectious Diseases Society of America (IDSA) has released updated recommendations for HIV positive people with chronic kidney disease. The guidelines, published in the September 17 issue of Clinical Infectious Diseases, state that antiretroviral therapy (ART) is beneficial for such patients, but they should avoid tenofovir (Viread, also in the Truvada, Atripla, Complera, and Stribild coformulations), which can cause kidney impairment.

alt

Monkey Transplant Study Rules Out Possible HIV Cure Mechanism

Macaque monkeys that received transplants of their own stem cells after undergoing intensive radiation that killed off their existing SHIV-infected immune cells experienced viral rebound soon after stopping antiretroviral drugs, indicating that pre-transplant "conditioning" was not solely responsible for the only known case of a person cured of HIV.

alt